Markets:

Overview

News

Currencies

International

Treasuries

Organon & Co. Common Stock (NY:OGN)

6.830 -0.010 (-0.15%)

Official Closing Price Updated: 7:00 PM EST, Dec 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Organon & Co. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

3 Healthcare Stocks with Questionable Fundamentals

December 15, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have...

Via StockStory

Topics Stocks

Why Organon (OGN) Shares Are Trading Lower Today

December 09, 2025

Shares of pharmaceutical company Organon (NYSE:OGN) fell 4.7% in the afternoon session after Barclays initiated coverage on the company with an 'Underweight' rating and a price target of $7.50. The new...

Via StockStory

Topics Initial Public Offering

3 Stocks Under $10 We Steer Clear Of

December 08, 2025

Stocks under $10 pique our interest because they have room to grow (as well as the most affordable option contract premiums). That doesn’t mean they’re bargains though, and we urge investors to be...

Via StockStory

Earnings Scheduled For November 10, 2025 ↗

November 10, 2025

Via Benzinga

A Look at Organon's Upcoming Earnings Report ↗

November 07, 2025

Via Benzinga

3 Value Stocks with Questionable Fundamentals

December 04, 2025

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued...

Via StockStory

3 Cash-Producing Stocks We Find Risky

December 03, 2025

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...

Via StockStory

Organon (OGN): Buy, Sell, or Hold Post Q3 Earnings?

November 30, 2025

Over the past six months, Organon’s stock price fell to $7.77. Shareholders have lost 16.1% of their capital, which is disappointing considering the S&P 500 has climbed by 14.7%. This may have...

Via StockStory

Topics Stocks

Q3 Rundown: Organon (NYSE:OGN) Vs Other Branded Pharmaceuticals Stocks

November 25, 2025

Wrapping up Q3 earnings, we look at the numbers and key takeaways for the branded pharmaceuticals stocks, including Organon (NYSE:OGN) and its peers.

Via StockStory

Topics Artificial Intelligence Intellectual Property

The 5 Most Interesting Analyst Questions From Organon’s Q3 Earnings Call

November 17, 2025

Organon's third quarter was marked by better-than-expected top-line and bottom-line results, which were well received by the market. Management attributed the quarter’s outperformance to strong...

Via StockStory

Topics Earnings

Organon (OGN) Stock Trades Down, Here Is Why

November 11, 2025

Shares of pharmaceutical company Organon (NYSE:OGN) fell 2.9% in the afternoon session after the company lowered its full-year sales guidance and analysts subsequently cut their price targets on the...

Via StockStory

Topics Artificial Intelligence Initial Public Offering Supply Chain

Organon Analysts Cut Their Forecasts Following Q3 Results ↗

November 11, 2025

Via Benzinga

OGN Q3 2025 Deep Dive: Leadership Changes, Portfolio Shifts, and Guidance Recalibration

November 11, 2025

Pharmaceutical company Organon (NYSE:OGN) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 1.3% year on year to $1.60 billion. On the other hand, the company’s...

Via StockStory

Tech Rallies, Palantir Jumps 6% As Shutdown End Looms: What's Moving Markets Monday? ↗

November 10, 2025

Wall Street rebounded on Monday, recovering part of last week's steep losses as investors grew more confident about risk assets amid encouraging signs from Washington that the record-long government...

Via Benzinga

Organon Cuts 2025 Sales Outlook Despite Earnings Beat ↗

November 10, 2025

Organon posts Q3 EPS of $1.01, topping estimates, trims 2025 sales outlook, and highlights positive Vtama data in children with atopic dermatitis.

Via Benzinga

Organon (NYSE:OGN) Posts Better-Than-Expected Sales In Q3

November 10, 2025

Via StockStory

Organon (OGN) Reports Earnings Tomorrow: What To Expect

November 08, 2025

Pharmaceutical company Organon (NYSE:OGN) will be announcing earnings results this Monday before market hours. Here’s what you need to know.

Via StockStory

Topics Artificial Intelligence

2 Safe-and-Steady Stocks with Impressive Fundamentals and 1 We Avoid

November 02, 2025

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.

Via StockStory

1 of Wall Street’s Favorite Stock with Impressive Fundamentals and 2 We Ignore

October 29, 2025

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because...

Via StockStory

Why Organon (OGN) Stock Is Down Today

October 28, 2025

Shares of pharmaceutical company Organon (NYSE:OGN) fell 8.9% in the afternoon session after the company announced the resignation of CEO Kevin Ali after an internal investigation uncovered improper...

Via StockStory

Topics Economy Government Initial Public Offering

Which stocks are moving on Monday? ↗

October 27, 2025

Looking for insights into the US markets one hour before the close of the markets on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

Keep an eye on the top gainers and losers in Monday's session. ↗

October 27, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 27, 2025

Via Benzinga

Gold Falls 3%; Carter's Shares Gain After Q3 Earnings ↗

October 27, 2025

Via Benzinga

Which stocks are gapping on Monday? ↗

October 27, 2025

The session on Monday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Via Chartmill

These stocks are moving in today's pre-market session ↗

October 27, 2025

Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

Organon CEO Kevin Ali Resigns Amid Audit Probe Into Wholesaler Sales Practices ↗

October 27, 2025

Organon said that the investigation found that certain wholesalers in the United States were asked to buy more Nexplanon than they needed.

Via Stocktwits

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 27, 2025

Via Benzinga

3 Small-Cap Stocks We Steer Clear Of

October 21, 2025

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside...

Via StockStory

1 Profitable Stock Worth Your Attention and 2 Facing Challenges

October 16, 2025

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Organon & Co. Common Stock (NY:OGN)

Headline News about Organon & Co. Common Stock

Starting at $3.75/week.

Subscribe Today